(R)-1-Boc-2,2-Dimethyl-4-hydroxymethyl-oxazolidine, 95.0%, 1g

4,6-Diiodopyrimidine, 95.0%, 1g

2,4-Dichloro-6-(methylsulfonyl)pyrimidine, 1g

5-(Ethoxycarbonyl)pyrazine-2-carboxylic acid, 5g

TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE-1-CARBOXYLATE, 95.0%, 250mg

2-Bromo-4-fluorophenol>98.0%(GC)(T)25g

4H-Dibenzo[de,g]quinoline-1,9-diol, 5,6,6a,7-tetrahydro-2,10-dimethoxy-, (6aS)-, 98%, 250mg

Inhibitor Cocktail Tissue

5-Chloro-1,4-dihydropyrimido[5,4-e][1,2,4]triazine, 98%, 100mg

1,4-Bis(vinyldimethylsilyl)benzene, 95.0%, 100g

Dde-L-Leu-ol, 98.0%, 250mg

TERT-BUTYL (3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PROPYL)CARBAMATE, 95%, 1g

5-[(2-Amino-1,3-thiazol-4-yl)methyl]-N-methyl-1,3,4-thiadiazol-2-amine, 95.0%, 5g